VIP and posterior cortical atrophy: The study aimed to prospectively evaluate the feasibility of diagnosing PCa using voided urine samples and by targeting the genomic VPAC (vasoactive intestinal peptide and pituitary adenylate cyclase‐activating peptide) receptors in comparison with multiparametric magnetic resonance imaging (mp‐MRI) in male patients (≥40 years of age) with lower urinary tract symptoms and having a serum PSA of >4 but <15 ng/ml.